Tolérance du méthotrexate : mythes et réalités.

Methotrexate is the cornerstone of conventional synthetic drug treatments used in rheumatology where it is the first line of drug therapy recommended in rheumatoid arthritis, psoriatic arthritis and active peripheral spondyloarthritis. Its use in IBD should not be hampered by possible fears of the prescriber who will above all want not to harm his patient. This update therefore aims to clarify the myths and highlight the clinical and biological realities associated with taking methotrexate. [ABSTRACT FROM AUTHOR]